Adem Deligonul

9PUBLICATIONS
85CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markersMedical mycologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
Promoter Methylation and Somatic Mutations in Cancer-Related Genes Are Associated with Hyperprogressive Disease in Patients with Malignant Melanoma and Renal Cell Carcinoma Receiving Anti-PD-1/PD-L1 Immunotherapy.

|Jun 25, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 23, 2026
Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH score.

|Mar 28, 2026
Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of 'Time to Castration Resistance', Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide.

Seda Sali, Arife Ulaş, Sibel Oyucu Orhan

|Feb 27, 2026
Association of IMP3 and CD10 Expression with Clinicopathological Features and Outcomes in Phyllodes Tumors: A Retrospective Single-Center Study.

Hülya Odabaşı Bükün, Erdem Çubukçu, Adem Deligönül

|Feb 27, 2026
Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer-Insights from a Systematic Review and Real-World Experience.

Sibel Oyucu Orhan, Bedrettin Orhan, Yağmur Çakır

Pageof 2

Frequent Collaborators

5 joint publications

Ahmet Bilgehan Sahin

5 joint publications

Türkkan Evrensel

4 joint publications

Mursel Sali

3 joint publications

Alper Coskun